Form 8-K - Current report:
SEC Accession No. 0001213900-21-048212
Filing Date
2021-09-15
Accepted
2021-09-15 16:05:24
Documents
13
Period of Report
2021-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147480-8k_chinapharma.htm   iXBRL 8-K 24661
2 FORM OF INCENTIVE STOCK OPTION GRANT AGREEMENT ea147480ex10-1_chinapharma.htm EX-10.1 23218
  Complete submission text file 0001213900-21-048212.txt   227851

Data Files

Seq Description Document Type Size
3 XBRL LABEL FILE cphi-20210909_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cphi-20210909_pre.xml EX-101.PRE 22380
5 XBRL SCHEMA FILE cphi-20210909.xsd EX-101.SCH 3057
6 EXTRACTED XBRL INSTANCE DOCUMENT ea147480-8k_chinapharma_htm.xml XML 3596
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 211255467
SIC: 2834 Pharmaceutical Preparations